cb011: a novel genome-engineered bcma-specific car-t cell therapy
Published 2 years ago • 136 plays • Length 2:10Download video MP4
Download video MP3
Similar videos
-
1:34
cctx-001: a novel car-t therapy for aml
-
4:17
novel car t-cell therapies for hematological malignancies: exploring new targets
-
1:53
the detection and management of mnts following bcma-directed car-t therapy
-
0:58
novel car-t constructs emerging in multiple myeloma for patients who experience loss of bcma
-
1:59
novel car-t constructs being investigated for the treatment of all
-
1:02
bcma-specific car-t cells for r/r multiple myeloma
-
1:06
novel third-generation tlr2 co-stimulatory car-t cells for b-cell malignancies
-
3:47
novel combination in mm: bcma car t-cells with a gamma secretase inhibitor
-
2:20
novel car-t products in the pipeline for multiple myeloma
-
2:10
driving the identification of novel t cell therapies
-
1:06
how will novel agents & car-t cells affect the future treatment landscape in b-all?
-
5:51
safety of hbi0101 (nxc-201), a novel academic anti-bcma car-t, in r/r al amyloidosis
-
1:02
the use of car-t cell products in a real-world setting
-
2:16
evaluating the safety and efficacy of novel anti-cd7 universal car-t therapy in r/r t-all and t-lbl
-
5:14
novel synthetic tcr and antigen receptor (star) t-cell therapy for b-all
-
1:20
novel testing techniques in scd: cell-by-cell magnetization analysis
-
2:02
alnuctamab, a bcma x cd3 tce, in the treatment of multiple myeloma
-
1:13
an insight into novel third-generation tlr2 co-stimulatory car-t cells